Top

Published in:

01-01-2021 | Tocilizumab

Aortic thrombus in patients with severe COVID-19: review of three cases

Authors: María de Carranza, Danilo-Eduardo Salazar, Jesús Troya, Roberto Alcázar, Cristina Peña, Esther Aragón, Marta Domínguez, Juan Torres, Nuria Muñoz-Rivas

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2021

Abstract

Coronavirus disease 2019 (COVID-19) could predispose to both venous and arterial thromboembolism, in an exaggerated immune response to the virus, especially in severe patients. Even though aortic clots are a rare entity, the pro-coagulant nature of COVID-19 is associated with thrombosis in atypical locations and should be considered in patients with severe abnormalities in coagulation parameters. We describe a series of three cases of aortic thrombi diagnosed by computerized tomography (CT) angiography in patients with confirmed SARS-CoV-2 infection.

World Health Organization, web-site. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 26 Apr, 2020

Lai CC, Shih TP, Ko WC et al (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55(3):105924. https://doi.org/10.1016/j.ijantimicag.2020.105924CrossRefPubMedPubMedCentral

Carod-Artal FJ (2020) Neurological complications of coronavirus and COVID-19. Rev Neurol 70(9):311–322. https://doi.org/10.33588/rn.7009.2020179CrossRefPubMed

Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O (2020) Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1286CrossRefPubMed

Xiong TY, Redwood S, Prendergast B, Chen M (2020) Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J 41(19):1798–1800. https://doi.org/10.1093/eurheartj/ehaa231CrossRefPubMed

Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res S0049–3848(20):30120–30121. https://doi.org/10.1016/j.thromres.2020.04.013CrossRef

Llitjos JF, Leclerc M, Chochois C et al (2020) High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. https://doi.org/10.1111/jth.14869.10.1111/jth.14869CrossRefPubMedPubMedCentral

Cui S, Chen S, Li X, Liu S, Wang F (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. https://doi.org/10.1111/jth.14830.10.1111/jth.14830CrossRefPubMedPubMedCentral

Beun R, Kusadasi N, Sikma M, Westerink J, Huisman A (2020) Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2. Int J Lab Hematol. https://doi.org/10.1111/ijlh.13230.10.1111/ijlh.13230CrossRefPubMedPubMedCentral

10.

Saif MW, Greenberg B (2001) HIV and thrombosis: a review. AIDS Patient Care STDS 15(1):15–24. https://doi.org/10.1089/108729101460065CrossRefPubMed

11.

Lushina N, Kuo JS, Shaikh HA (2020) Pulmonary, cerebral, and renal thromboembolic disease associated with COVID-19 infection. Radiology. https://doi.org/10.1148/radiol.2020201623CrossRefPubMed

12.

Panigada M, Bottino N, Tagliabue P et al (2020) Hypercoagulability of COVID-19 patients in Intensive Care Unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. https://doi.org/10.1111/jth.14850CrossRefPubMedPubMedCentral

13.

Bikdeli B, Madhavan MV, Jimenez D et al (2020) COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol S0735–1097(20):35008–35017. https://doi.org/10.1016/j.jacc.2020.04.031CrossRef

14.

Le Berre A, Marteau V, Emmerich J, Zins M (2020) Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia. Diagn Interv Imaging. 101(5):321–322. https://doi.org/10.1016/j.diii.2020.04.003CrossRefPubMedPubMedCentral

15.

Han H, Yang L, Liu R et al (2020) Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. https://doi.org/10.1515/cclm-2020-0188CrossRefPubMed

16.

Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endothelitis in COVID-19. Lancet 395(10234):1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-510CrossRefPubMedPubMedCentral

17.

Frantzeskaki F, Armaganidis A, Orfanos SE (2017) Immunothrombosis in acute respiratory distress syndrome: cross talks between inflammation and coagulation. Respiration 93(3):212–225. https://doi.org/10.1159/000453002CrossRefPubMed

18.

Connors JM, Levy JH (2020) Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. https://doi.org/10.1111/jth.14849.10.1111/jth.14849CrossRefPubMedPubMedCentral

19.

Aksu AO, Demirkazik FB (2010) Floating aortic thrombus in a patient with non-Hodgkin’s Lymphoma. Diagn Interv Radiol 16(1):63–65. https://doi.org/10.4261/1305-3825.DIR.1226-07.1CrossRefPubMed

20.

MacNamara D. COVID-19 Linked to Large Vessel Stroke in Young Adults. Medscape. 2020. https://www.medscape.com/viewarticle/929345. Accessed 26 May, 2020

Title: Aortic thrombus in patients with severe COVID-19: review of three cases
Authors: María de Carranza
Danilo-Eduardo Salazar
Jesús Troya
Roberto Alcázar
Cristina Peña
Esther Aragón
Marta Domínguez
Juan Torres
Nuria Muñoz-Rivas
Publication date: 01-01-2021
Publisher: Springer US
Keywords: Tocilizumab
Anticoagulant
SARS-CoV-2
Pneumonia
CT Angiography
COVID-19
Enoxaparin
Published in: Journal of Thrombosis and Thrombolysis / Issue 1/2021
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02219-z

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation

Highlights from the European society of cardiology congress 2020

Impacts of in-hospital workflow on functional outcome in stroke patients treated with endovascular thrombectomy

Decreased size of the left anterior descending coronary artery is an independent predictor of deterioration in non-high-risk patients with acute pulmonary embolism

Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation

Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage